Welcome to our dedicated page for Gannett Co SEC filings (Ticker: GCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
USA TODAY, 200+ local papers, a U.K. publishing arm, and a fast-growing marketing tech unit—Gannett’s business model generates disclosures that span everything from newsroom restructuring costs to digital subscription metrics. Finding those details in a 300-page 10-K is difficult. That’s why this page delivers every Gannett insider trading Form 4 transactions, Gannett quarterly earnings report 10-Q filing, and material 8-K in one place.
Stock Titan’s AI reads each document the moment it hits EDGAR, then serves you:
- Plain-English summaries that turn footnotes on pension obligations or goodwill impairments into actionable data
- Real-time alerts for Gannett Form 4 insider transactions—see executive buys or sales before markets open
- Side-by-side trend tables so you can track digital vs. print revenue across quarters without downloading PDFs
Not sure where to look for segment margins? Our AI highlights exactly where Domestic Media, Newsquest, and Digital Marketing Solutions numbers sit inside the 10-Q. Curious about board pay? Jump straight to the Gannett proxy statement executive compensation section, already annotated. Need to react to breaking news? The latest Gannett 8-K material events explained panel flags layoffs, acquisitions, or debt refinancings minutes after filing.
Whether you’re screening for Gannett executive stock transactions Form 4, comparing cash-flow swings, or simply understanding Gannett SEC documents with AI, this hub condenses every filing type—10-K annual reports, 10-Q quarterly updates, Form 4 trades, S-3 offerings—into insights you can use immediately.
Vir Biotechnology, Inc. (VIR) – Form 144 filing overview
The filing discloses a proposed secondary sale of 66,000 common shares of Vir Biotechnology under Rule 144. The shares were originally acquired on 17 Jan 2017 as pre-IPO stock and are held in the name of an undisclosed insider (the form does not specify the individual or relationship to the issuer). Morgan Stanley Smith Barney LLC, Executive Financial Services, is listed as the broker for the transaction.
- Shares to be sold: 66,000
- Aggregate market value: US $332,640
- Planned sale date: 1 Jul 2025
- Total VIR shares outstanding: 138,238,003
- Percent of shares outstanding: ~0.05 % (66,000 ÷ 138,238,003)
- Exchange: NASDAQ
No sales by the filer have occurred within the prior three months, and the securities were not purchased with non-cash consideration according to the disclosure. The seller certifies awareness of no undisclosed material adverse information and acknowledges potential criminal liability for misstatements.
Given the modest size relative to VIR’s float and the absence of multiple tranches or recent insider selling, this notice is unlikely to have a material impact on the company’s capital structure or market dynamics. However, investors may monitor for additional filings that could signal a broader disposition program.
John Wiley & Sons, Inc. (WLYB) has filed a Form 144 indicating an intended sale of 5,665 shares of its common stock through UBS Financial Services on the NYSE, with an aggregate market value of $250,053. Based on the figures supplied, the reference price is roughly $44 per share. The shares to be sold represent approximately 0.013 % of the company’s 44.62 million shares outstanding, making the planned disposition immaterial in percentage terms.
The stock was acquired via the vesting of multiple tranches of restricted stock units (RSUs) and performance share units (RPSUs) granted between April 2021 and April 2023. Tranche sizes range from 191 to 1,565 shares, reflecting normal equity-compensation practices. The filer reported no sales during the prior three-month period and certified the absence of undisclosed material adverse information.
Form 144 is a notice of proposed, not completed, sales. The filing does not disclose the seller’s identity, whether a Rule 10b5-1 trading plan exists, or final execution prices. Given the modest size of the transaction and its origin from routine incentive-compensation vesting, the event is unlikely to influence WLYB’s share price materially, but it remains a data point for investors monitoring insider-selling patterns.
FAQ
What is the current stock price of Gannett Co (GCI)?
What is the market cap of Gannett Co (GCI)?
What is the core business of Gannett Co Inc?
How does Gannett generate revenue?
What are the primary business segments of Gannett?
How does Gannett maintain its competitive edge in the media industry?
What role does digital transformation play at Gannett?
How does Gannett serve both local and national audiences?
What distinguishes Gannett's digital marketing solutions?
How does Gannett engage with industry events and community initiatives?
